NDC 51267-890 – Contrave Extended-Release
Naltrexone Hydrochloride 8 mg/1; Bupropion Hydrochloride 90 mg/1 · Tablet, Extended Release · Oral
Product NDC51267-890
Product details
- Brand name
- Contrave Extended-Release
- Generic name
- Naltrexone hydrochloride and bupropion hydrochloride
- Labeler
- Nalpropion Pharmaceuticals LLC
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- NDA · NDA200063
- Marketed since
- October 22, 2014
- Listing expires
- December 31, 2026
- Pharmacologic class
- Aminoketone; Opioid Antagonist
Active ingredients
- Naltrexone Hydrochloride 8 mg/1
- Bupropion Hydrochloride 90 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 51267-890-07 sample | 7 TABLET, EXTENDED RELEASE in 1 BOTTLE (51267-890-07) | Jan 14, 2021 |
| 51267-890-99 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (51267-890-99) | Oct 22, 2014 |
Recalls mentioning this NDC
- D-0219-2019 Nov 14, 2018 · Class III
Container packaging defect. - D-1099-2018 Aug 22, 2018 · Class III
Defective Container: Customer complaints of punctures in the bottle.